Drug treatment for hypertension
420 results
101 - 200
Medical treatment of glaucoma and intraocular hypertension 
Spironolactone most effective add-on for patients with resistant hypertension (PATHWAY-2)- Follow-up of type 1 diabetes
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension: Cochrane systematic review- Pharmacological interventions for hypertensive emergencies
- Calcium channel blockers versus other classes of drugs for hypertension
- Drugs for treatment of very high blood pressure during pregnancy
- Metabolic syndrome
- Pharmacotherapy for hypertension in adults 60 years or older
- Evening versus morning dosing regimen drug therapy for hypertension
- Secondary hypertension
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Diabetic kidney disease (diabetic nephropathy)
- Some benefit to treating mild hypertension to prevent stroke, CV deaths, and overall mortality
- Alcohol or drug intoxication
- Spironolactone for hypertension
- Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus: Cochrane systematic review
- Gout and pseudogout
- Comprehensive treatment and follow-up of type 2 diabetes
- Pharmacotherapy for hyperuricaemia in hypertensive patients
- Acute heart failure and pulmonary oedema
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Blood pressure-lowering efficacy of loop diuretics for primary hypertension: Cochrane systematic review
- Beta-blockers against other antihypertensive drugs
- Blood pressure targets for hypertension in people with chronic renal disease
- Guided imagery for treating hypertension in pregnancy
- Greater blood pressure lowering with a “quadpill” (quarter doses of 4 drugs) than with standard-dose monotherapy (QUARTET)
- Chronic heart failure
- Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates
- Adrenergic drugs for urinary incontinence in adults: Cochrane systematic review
- Blood pressure lowering efficacy of diuretics as second‐line therapy for primary hypertension
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension: Cochrane systematic review
- Blood pressure‐lowering efficacy of reserpine for primary hypertension
- Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction: Cochrane systematic review
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Higher blood pressure targets for hypertension in older adults
- 24-hour ambulatory blood pressure readings: more informative for the risks of all-cause and cardiovascular mortality
- Adverse effects of hypertension treatment during pregnancy
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension: Cochrane systematic review
- Hydralazine for essential hypertension
- Treatment of drug addicts
- Pharmacological interventions for hypertension in children
- Direct oral anticoagulants
- Blood pressure targets for people with hypertension and cardiovascular disease
- Long‐term effects of weight‐reducing drugs in people with hypertension
- Pharmacotherapy for hypertension‐induced left ventricular hypertrophy
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
- Renin inhibitors versus angiotensin receptor blockers for primary hypertension
- Interventions used to improve control of blood pressure in patients with hypertension
- One-third of people eligible for weight loss drugs are not represented in clinical research
- Spironolactone for hypertension: Cochrane systematic review
- Blood pressure lowering for prevention of dementia in patients without prior cerebrovascular disease
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Reversal of left ventricular hypertrophy in essential hypertension
- Nonsteroidal anti‐inflammatory drugs (NSAIDS) versus opioids for acute renal colic
- BP lowering by any means is beneficial in most
- Beta‐blockers for hypertension
- Subcutaneous trepostinil for pulmonary hypertension
- Oral antidiabetic drugs and GLP-1 analogues
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
- Hypokalaemia
- Relaxation therapies for the management of primary hypertension in adults
- Drugs for rapid treatment of very high blood pressure during pregnancy
- Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
- Vascular cognitive impairment (VCI)
- Methyldopa for primary hypertension: Cochrane systematic review
- Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension
- Health gains from the treatment of obesity
- Good reasons not to lower the definition of high blood pressure in adults
- Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Identification of illegal drug overdose and diagnosis of illegal drug poisoning
- Acupuncture for hypertension
- Systemic lupus erythematosus (SLE)
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Endothelin receptor antagonists for pulmonary arterial hypertension
- Interventions for idiopathic intracranial hypertension
- Hypertension in elderly patients
- Epistaxis
- Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection: Cochrane systematic review
- Headache